• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽类激素对血管生成的调节。

Peptide hormone regulation of angiogenesis.

作者信息

Clapp Carmen, Thebault Stéphanie, Jeziorski Michael C, Martínez De La Escalera Gonzalo

机构信息

Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, Mexico.

出版信息

Physiol Rev. 2009 Oct;89(4):1177-215. doi: 10.1152/physrev.00024.2009.

DOI:10.1152/physrev.00024.2009
PMID:19789380
Abstract

It is now apparent that regulation of blood vessel growth contributes to the classical actions of hormones on development, growth, and reproduction. Endothelial cells are ideally positioned to respond to hormones, which act in concert with locally produced chemical mediators to regulate their growth, motility, function, and survival. Hormones affect angiogenesis either directly through actions on endothelial cells or indirectly by regulating proangiogenic factors like vascular endothelial growth factor. Importantly, the local microenvironment of endothelial cells can determine the outcome of hormone action on angiogenesis. Members of the growth hormone/prolactin/placental lactogen, the renin-angiotensin, and the kallikrein-kinin systems that exert stimulatory effects on angiogenesis can acquire antiangiogenic properties after undergoing proteolytic cleavage. In view of the opposing effects of hormonal fragments and precursor molecules, the regulation of the proteases responsible for specific protein cleavage represents an efficient mechanism for balancing angiogenesis. This review presents an overview of the actions on angiogenesis of the above-mentioned peptide hormonal families and addresses how specific proteolysis alters the final outcome of these actions in the context of health and disease.

摘要

现在很明显,血管生长的调节有助于激素对发育、生长和繁殖的经典作用。内皮细胞处于理想位置来响应激素,激素与局部产生的化学介质协同作用,调节内皮细胞的生长、运动、功能和存活。激素可通过直接作用于内皮细胞或间接调节血管内皮生长因子等促血管生成因子来影响血管生成。重要的是,内皮细胞的局部微环境可决定激素对血管生成作用的结果。对血管生成具有刺激作用的生长激素/催乳素/胎盘催乳素系统、肾素-血管紧张素系统和激肽释放酶-激肽系统的成员,在经历蛋白水解切割后可获得抗血管生成特性。鉴于激素片段和前体分子的相反作用,负责特定蛋白切割的蛋白酶的调节代表了一种平衡血管生成的有效机制。本综述概述了上述肽类激素家族对血管生成的作用,并探讨了在健康和疾病背景下特定蛋白水解如何改变这些作用的最终结果。

相似文献

1
Peptide hormone regulation of angiogenesis.肽类激素对血管生成的调节。
Physiol Rev. 2009 Oct;89(4):1177-215. doi: 10.1152/physrev.00024.2009.
2
Making the cut: protease-mediated regulation of angiogenesis.精准调控:蛋白酶介导的血管生成调节
Exp Cell Res. 2006 Mar 10;312(5):608-22. doi: 10.1016/j.yexcr.2005.11.022. Epub 2006 Jan 24.
3
Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis.催乳素及催乳素/生长激素/胎盘催乳素家族相关成员在血管生成中的作用。
J Endocrinol. 2002 May;173(2):219-38. doi: 10.1677/joe.0.1730219.
4
Hormone regulation of endothelial apoptosis and proliferation in vessel regression and angiogenesis.激素对血管消退和血管生成过程中内皮细胞凋亡与增殖的调节作用。
Microsc Res Tech. 2003 Jan 1;60(1):59-63. doi: 10.1002/jemt.10243.
5
Vasoinhibins: endogenous regulators of angiogenesis and vascular function.血管抑制素:血管生成和血管功能的内源性调节因子。
Trends Endocrinol Metab. 2006 Oct;17(8):301-7. doi: 10.1016/j.tem.2006.08.002. Epub 2006 Aug 23.
6
Peptide hormones as developmental growth and differentiation factors.作为发育生长和分化因子的肽类激素。
Dev Dyn. 2008 Jun;237(6):1537-52. doi: 10.1002/dvdy.21573.
7
Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.催乳素/生长激素衍生的抗血管生成肽突显了倾斜肽在血管生成中的潜在作用。
Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14319-24. doi: 10.1073/pnas.0606638103. Epub 2006 Sep 14.
8
Update on endogenous inhibitors of angiogenesis.血管生成内源性抑制剂的最新进展。
Endothelium. 2006 Mar-Apr;13(2):147-55. doi: 10.1080/1062332060069110.
9
Nonclassic endogenous novel [corrected] regulators of angiogenesis.非经典内源性新型[校正后]血管生成调节因子。
Pharmacol Rev. 2007 Jun;59(2):185-205. doi: 10.1124/pr.59.2.3.
10
Extracellular proteolysis and angiogenesis.细胞外蛋白水解与血管生成
Thromb Haemost. 2001 Jul;86(1):346-55.

引用本文的文献

1
The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability.抗血管生成肽VIAN-c4551通过降低肺血管通透性抑制小鼠肺黑色素瘤转移。
PLoS One. 2025 May 28;20(5):e0316983. doi: 10.1371/journal.pone.0316983. eCollection 2025.
2
Angiogenesis, signaling pathways, and animal models.血管生成、信号通路与动物模型。
Chin Med J (Engl). 2025 May 20;138(10):1153-1162. doi: 10.1097/CM9.0000000000003561. Epub 2025 Apr 21.
3
Vasoinhibin is Generated by the Renin-angiotensin System.
血管抑制素由肾素-血管紧张素系统产生。
Endocrinology. 2025 Feb 5;166(3). doi: 10.1210/endocr/bqaf023.
4
Transcriptome sequencing and Mendelian randomization analysis identified biomarkers related to neutrophil extracellular traps in diabetic retinopathy.转录组测序和孟德尔随机化分析鉴定了与糖尿病视网膜病变中性粒细胞胞外陷阱相关的生物标志物。
Front Immunol. 2024 Oct 17;15:1408974. doi: 10.3389/fimmu.2024.1408974. eCollection 2024.
5
Dopamine D2 receptor antagonist counteracts hyperglycemia and insulin resistance in diet-induced obese male mice.多巴胺 D2 受体拮抗剂可对抗饮食诱导肥胖雄性小鼠的高血糖和胰岛素抵抗。
PLoS One. 2024 Apr 18;19(4):e0301496. doi: 10.1371/journal.pone.0301496. eCollection 2024.
6
Harnessing Endogenous Peptide Compounds as Potential Therapeutics for Severe Influenza.利用内源性肽化合物作为严重流感的潜在治疗方法。
J Infect Dis. 2024 Aug 16;230(2):e384-e394. doi: 10.1093/infdis/jiad566.
7
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial.左舒必利治疗糖尿病性黄斑水肿的 2 期随机临床试验。
Eye (Lond). 2024 Feb;38(3):520-528. doi: 10.1038/s41433-023-02715-5. Epub 2023 Sep 6.
8
Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease.基于可注射水凝胶的治疗性血管生成用于缺血性心脏病中的蛋白质递送
iScience. 2023 Apr 10;26(5):106577. doi: 10.1016/j.isci.2023.106577. eCollection 2023 May 19.
9
Microvascular proliferation in arteriovenous malformation of the hand worsens during pregnancy: a case report.手部动静脉畸形中的微血管增殖在孕期恶化:一例报告
Ann Med Surg (Lond). 2023 Apr 12;85(4):1262-1269. doi: 10.1097/MS9.0000000000000507. eCollection 2023 Apr.
10
Non-pituitary GH regulation of the tissue microenvironment.非垂体 GH 对组织微环境的调节。
Endocr Relat Cancer. 2023 Jun 1;30(7). doi: 10.1530/ERC-23-0028. Print 2023 Jul 1.